Michael Lisjak
General Counsel at CYCLO THERAPEUTICS, INC.
Net worth: 15 996 $ as of 2024-04-29
Profile
Michael Lisjak is currently the Chief Regulatory Officer at Cyclo Therapeutics, Inc. He previously worked as the Director-Worldwide Regulatory Strategy at Pfizer Inc. and as the Head-Global Regulatory Affairs at Sanofi SA. He completed his undergraduate degree at Rochester Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYCLO THERAPEUTICS INC
0.04% | 2024-02-29 | 12,400 ( 0.04% ) | 15 996 $ | 2024-04-29 |
Michael Lisjak active positions
| Companies | Position | Start |
|---|---|---|
| CYCLO THERAPEUTICS, INC. | General Counsel | 2019-07-07 |
Former positions of Michael Lisjak
| Companies | Position | End |
|---|---|---|
| Sanofi SA | General Counsel | 2016-05-31 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Training of Michael Lisjak
| Rochester Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| Sanofi SA | Health Technology |
- Stock Market
- Insiders
- Michael Lisjak